Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation

doi:10.1053/gast.1997.v113.pm9247457

Gastroenterology

Volume 113, Issue 2, August 1997, Pages 409-414

https://doi.org/10.1053/gast.1997.v113.pm9247457 Get rights and content

Abstract

BACKGROUND & AIMS: Morphine increases residual lower esophageal sphincter (LES) pressure during swallow-induced LES relaxation to levels shown experimentally to prevent reflux. The hypothesis that morphine reduces reflux by increasing residual LES pressure during transient LES relaxation was tested in 8 healthy subjects and 8 patients with reflux disease.

METHODS: Esophageal pH, LES, and esophageal pressures were recorded simultaneously during three sequential 30-minute periods, basal, after morphine, and after naloxone, while the stomach was distended by constant infusion of 10% dextrose.

RESULTS: Morphine decreased the number of reflux episodes and the time at pH < 4 in the patients (3.0 +/- 0.5 vs. 6.2 +/- 1.0 [P < 0.02] and 44% +/- 7% vs. 64% +/- 7% [P < 0.05], respectively) but not in the healthy subjects (P = NS). Transient LES relaxation was the major mechanism of reflux, and although morphine did not affect residual LES pressure during transient LES relaxations, it decreased their number markedly in the patients (3.0 +/- 0.5 vs. 6.6 +/- 1.7 [P < 0.05]) and marginally in the healthy subjects (2.1 +/- 0.4 vs. 2.6 +/- 0.4; P = NS). Naloxone completely reversed the effects of morphine.

CONCLUSIONS: Morphine reduces reflux in patients with reflux disease by decreasing the number of transient LES relaxations.

(Gastroenterology 1997 Aug;113(2):409-14)

References (0)

Cited by (146)

Pharmacologic causes of dysphagia
2023, Dysphagia: Diagnosis and Treatment of Esophageal Motility Disorders
Dysphagia is a major side effect of many medications. However, prior to implicating a medication as the cause of a patient's dysphagia, other causes of dysphagia should be ruled out with a thorough diagnostic evaluation. Medications can cause dysphagia by several mechanisms: systemic effects, therapeutic action, direct mucosal injury, and opioid induced esophageal dysmotility. Direct mucosal injury can be related to the production of caustic acidic solution, production of caustic alkalotic solution, production of hyperosmolar solution in contact with the esophageal mucosa, and/or direct toxicity. Opioid-induced esophageal dysfunction is a growing concern due to the opioid epidemic. Opioid use interferes with the inhibitory signals involved in esophageal motility. This subsequently leads to unchecked excitatory stimuli leading to vigorous, rapid, or simultaneous contractions in the esophagus and impaired lower esophageal sphincter relaxation. The treatment of medication-induced dysphagia centers around the identification and discontinuation of the offending agent. In patients who complete opioid cessation is not possible, decreasing the strength of the opioid, or decreasing the dose of the opioid is a reasonable strategy.
The opioid-P2Y<inf>12</inf> inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction
2021, Pharmacology and Therapeutics
Despite advances in medical and interventional management of acute myocardial infarction, treatment of the associated chest pain has remained relatively unchanged since opioids were first utilized in the 1930’s. This dominance can be partially attributed to initial studies suggesting hemodynamic benefits with opioid treatment. However, delayed gastrointestinal absorption of P2Y₁₂ inhibitors due to opioids and the consequent impairment in antiplatelet activity of this established therapy is cause for concern. Coupled with the lack of randomized clinical trial evidence to support widespread opioid use, there is now an opportunity to re-evaluate our approach to analgesia in myocardial infarction. This review characterizes the mechanism of the opioid-P2Y₁₂ inhibitor interaction, strategies aimed at mitigating the interaction and appraises promising alternative agents to opioid therapy in patients with myocardial infarction.
Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits
2017, Clinical Gastroenterology and Hepatology
Citation Excerpt :
Mu opioids may be associated with dysphagia or heartburn that may reflect intrinsic neural or sphincter dysfunction. In patients with gastroesophageal reflux disease,37 acute morphine administration significantly decreases the rate of transient LES relaxations in patients vs controls, resulting in less reflux episodes and a decrease of the time at pH <4. Resting LES pressure is decreased both in health and in achalasia; swallow-induced LES relaxation is also significantly decreased by morphine in the healthy subjects.29
The use of opioid medications on both an acute and chronic basis is ubiquitous in the United States. As opioid receptors densely populate the gastrointestinal tract, symptoms and side effects can be expected in these patients. In the esophagus, dysmotility may result, manifesting with dysphagia and a syndrome indistinguishable from primary achalasia. In the stomach, a marked delay in gastric emptying may occur with postprandial nausea and early satiety. Postoperatively, particularly with abdominal surgery, opioid-induced ileus may ensue. In the colon, opioid-induced constipation is common. A unique syndrome termed narcotic bowel syndrome is characterized by chronic abdominal pain often accompanied by nausea and vomiting in the absence of other identifiable causes. With the recognition of the important role of opioids on gastrointestinal function, novel drugs have been developed that use this physiology. These medications include peripheral acting opioid agonists to treat opioid-induced constipation and combination agonist and antagonists used for diarrhea-predominant irritable bowel syndrome. This review summarizes the most recent data in these areas.
Effects of Codeine on Esophageal Peristalsis in Patients With Ineffective Esophageal Motility: Studies Using High-resolution Manometry
2024, Journal of Neurogastroenterology and Motility
Evaluation of Esophageal Dysphagia in Elderly Patients
2023, Current Gastroenterology Reports
Impact of opioids on esophageal motility
2023, Neurogastroenterology and Motility

View all citing articles on Scopus

View full text